Targeted antibiotic gel helps 80% of pilot patients avoid foot amputation, Jerusalem trial finds

GentaGel’s biodegradable treatment releases antibiotics directly at infection sites for up to 60 days; the company is pursuing further trials and an FDA regulatory pathway.